Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 
Project Element Element Description

Project Title

Project Title

Controlled trial of sertraline in young children with Fragile X Syndrome

Principal Investigator

Principal Investigator

Hagerman, Randi

Description

Description

This project is a controlled trial of sertraline, a selective serotonin reuptake inhibitor (SSRI), for the treatment of children with fragile X syndrome (FXS) between 24-68 months of age.

Funder

Funder

Health Resources and Services Administration

Fiscal Year Funding

Fiscal Year Funding

285943

Current Award Period

Current Award Period

2011-2014

Strategic Plan Question

Strategic Plan Question

Question 4: Which Treatments And Interventions Will Help?

Strategic Plan Objective

Strategic Plan Objective

Yellow dot: Objective has some degree of funding, but less than the recommended amount. 4LA. Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.

Project Link

Project Link

Controlled trial of sertraline in young children with Fragile X Syndrome (External web link)

Institution

Institution

University of California, Davis

State/Country

State/Country

California

Project Number

Project Number

R40 MC 22641

Federal or Private?

Federal or Private?

Federal

Received ARRA Funding?

Received ARRA Funding?

No

History/Related Projects

History/Related Projects

Controlled trial of sertraline in young children with Fragile X Syndrome | 285177 | 2011 | R40 MC 22641
Controlled trial of sertraline in young children with Fragile X Syndrome | 285970 | 2012 | R40 MC 22641
Controlled trial of sertraline in young children with Fragile X Syndrome | 0 | 2014 | R40 MC 22641

 
Back to Top